Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Variability of bone response to hormone replacement therapy]

J C Ruiz1, A Tamborini, P Neftel

  • 1Hôpital Boucicaut, Service de Gynécologie-Obstétrique, Paris.

Revue Francaise De Gynecologie Et D'Obstetrique
|May 1, 1995
PubMed
Summary

Hormone replacement therapy (HRT) effectively increases bone density in post-menopausal women. Peri-menopausal women showed stability with HRT, unlike controls who lost bone mass, suggesting HRT benefits bone health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment outcomes in sinonasal aspergillosis in dogs in the United Kingdom: 436 cases (2011-2021).

The Journal of small animal practice·2025
Same author

Diagnostic findings in sinonasal aspergillosis in dogs in the United Kingdom: 475 cases (2011-2021).

The Journal of small animal practice·2024
Same author

Long-term clinical outcomes of preoperative brachytherapy in early-stage cervical cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2024
Same author

Impact of preoperative brachytherapy followed by radical hysterectomy in stage IB2 (FIGO 2018) cervical cancer: An analysis of SENTICOL I-II trials.

Gynecologic oncology·2023
Same author

Discovery of peritoneal carcinomatosis on <sup>18</sup>F-fluorocholine PET/CT performed for primary hyperparathyroidism.

Revista espanola de medicina nuclear e imagen molecular·2023
Same author

[A curriculum based certification of competence in gynaecologic surgical oncology].

Gynecologie, obstetrique, fertilite & senologie·2021

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Gerontology

Background:

  • Bone loss is a significant concern for menopausal women.
  • Hormone replacement therapy (HRT) is a common intervention for menopausal symptoms.
  • The impact of HRT on bone density varies depending on menopausal status.

Purpose of the Study:

  • To assess the bone response to hormone replacement therapy (HRT) in post-menopausal and peri-menopausal women.
  • To compare bone density changes in women receiving HRT versus controls.
  • To identify factors influencing bone response to HRT.

Main Methods:

  • Retrospective longitudinal study design.
  • 115 women initiating HRT and 252 controls.
  • Densitometric evaluation of spine and femur at baseline and ~29 months.

Related Experiment Videos

  • Classification of women as post-menopausal (>6 months amenorrhea) or peri-menopausal (<6 months amenorrhea).

    • Main Results:

    • Post-menopausal women on HRT showed significant spinal (+2.85%/year) and femoral (+1.06%/year) bone gain.
    • Peri-menopausal women on HRT experienced no bone gain but demonstrated stability compared to controls' significant bone loss.
    • Response varied by menopausal stage and time since menopause; initial bone mass was a predictor.

    Conclusions:

    • HRT is effective in increasing bone density in post-menopausal women.
    • HRT stabilizes bone density in peri-menopausal women, preventing bone loss seen in controls.
    • Densitometric monitoring is recommended for individuals with low initial bone mass, especially when considering HRT.